DETECTION OF INCREASED LEVELS OF CIRCULATING INTERCELLULAR-ADHESION MOLECULE-1 IN SOME PATIENTS WITH RHEUMATOID-ARTHRITIS BUT NOT IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS - LACK OF CORRELATION WITH LEVELS OF CIRCULATING VASCULAR CELL-ADHESION MOLECULE-1

被引:156
作者
MASON, JC [1 ]
KAPAHI, P [1 ]
HASKARD, DO [1 ]
机构
[1] HAMMERSMITH HOSP,ROYAL POSTGRAD MED SCH,DEPT MED,RHEUMATOL UNIT,LONDON W12 0HS,ENGLAND
来源
ARTHRITIS AND RHEUMATISM | 1993年 / 36卷 / 04期
基金
英国惠康基金;
关键词
D O I
10.1002/art.1780360412
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To compare the levels of circulating intercellular adhesion molecule 1 (cICAM-1) and vascular cell adhesion molecule I (cVCAM-1) in patients with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). Methods. Levels of cICAM-1 and cVCAM-1 were measured in both plasma and synovial fluid using monoclonal antibody sandwich enzyme-linked immunoassays. Results. Levels of both cICAM-1 and cVCAM-1 were significantly increased (P < 0.001) in RA patients compared with normal controls. In contrast, only cVCAM-1, and not cICAM-1, was increased in patients with SLE. Levels of cICAM-1 and cVCAM-1 were significantly elevated in synovial fluid compared with plasma in paired samples from patients with RA. There was no correlation between levels of cICAM-1 and levels of cVCAM-1, in either plasma or synovial fluid. Whereas levels of cVCAM-1 correlated significantly with the erythrocyte sedimentation rate (ESR) and C-reactive protein level in RA patients and with the ESR in SLE patients, no significant correlations were found between cICAM-1 and either of these indices of disease activity. Conclusion. These observations indicate that levels of cICAM-1 and cVCAM-1 reflect separate pathophysiologic processes. Both may be useful markers for the diagnosis and management of patients with rheumatic diseases.
引用
收藏
页码:519 / 527
页数:9
相关论文
共 38 条
[1]   THE AMERICAN-RHEUMATISM-ASSOCIATION 1987 REVISED CRITERIA FOR THE CLASSIFICATION OF RHEUMATOID-ARTHRITIS [J].
ARNETT, FC ;
EDWORTHY, SM ;
BLOCH, DA ;
MCSHANE, DJ ;
FRIES, JF ;
COOPER, NS ;
HEALEY, LA ;
KAPLAN, SR ;
LIANG, MH ;
LUTHRA, HS ;
MEDSGER, TA ;
MITCHELL, DM ;
NEUSTADT, DH ;
PINALS, RS ;
SCHALLER, JG ;
SHARP, JT ;
WILDER, RL ;
HUNDER, GG .
ARTHRITIS AND RHEUMATISM, 1988, 31 (03) :315-324
[2]  
BECKER JC, 1991, J IMMUNOL, V147, P4398
[3]   INTERCELLULAR-ADHESION MOLECULE-1 IS AN ENDOTHELIAL-CELL ADHESION RECEPTOR FOR PLASMODIUM-FALCIPARUM [J].
BERENDT, AR ;
SIMMONS, DL ;
TANSEY, J ;
NEWBOLD, CI ;
MARSH, K .
NATURE, 1989, 341 (6237) :57-59
[4]   ADHESION OF HUMAN BASOPHILS, EOSINOPHILS, AND NEUTROPHILS TO INTERLEUKIN 1-ACTIVATED HUMAN VASCULAR ENDOTHELIAL-CELLS - CONTRIBUTIONS OF ENDOTHELIAL-CELL ADHESION MOLECULES [J].
BOCHNER, BS ;
LUSCINSKAS, FW ;
GIMBRONE, MA ;
NEWMAN, W ;
STERBINSKY, SA ;
DERSEANTHONY, CP ;
KLUNK, D ;
SCHLEIMER, RP .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (06) :1553-1556
[5]  
CARLOS T, 1991, BLOOD, V77, P2266
[6]   BINDING OF THE INTEGRIN MAC-1 (CD11B/CD18) TO THE 3RD IMMUNOGLOBULIN-LIKE DOMAIN OF ICAM-1 (CD54) AND ITS REGULATION BY GLYCOSYLATION [J].
DIAMOND, MS ;
STAUNTON, DE ;
MARLIN, SD ;
SPRINGER, TA .
CELL, 1991, 65 (06) :961-971
[7]   THE FUNCTION OF HUMAN INTERCELLULAR-ADHESION MOLECULE-1 (ICAM-1) IN THE GENERATION OF AN IMMUNE-RESPONSE [J].
DOUGHERTY, GJ ;
MURDOCH, S ;
HOGG, N .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1988, 18 (01) :35-39
[8]   ADHESION OF T-LYMPHOBLASTS TO EPIDERMAL-KERATINOCYTES IS REGULATED BY INTERFERON-GAMMA AND IS MEDIATED BY INTERCELLULAR-ADHESION MOLECULE-1 (ICAM-1) [J].
DUSTIN, ML ;
SINGER, KH ;
TUCK, DT ;
SPRINGER, TA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 167 (04) :1323-1340
[9]   LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN-1 (LFA-1) INTERACTION WITH INTERCELLULAR-ADHESION MOLECULE-1 (ICAM-1) IS ONE OF AT LEAST 3 MECHANISMS FOR LYMPHOCYTE ADHESION TO CULTURED ENDOTHELIAL-CELLS [J].
DUSTIN, ML ;
SPRINGER, TA .
JOURNAL OF CELL BIOLOGY, 1988, 107 (01) :321-331
[10]  
DUSTIN ML, 1986, J IMMUNOL, V137, P245